RxDoctor Payments Data

Richard Reitman, MD

Adult Reconstructive Orthopaedic Surgery · Plano, TXNPI 1811938129

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $184,352 of the $227,265 with a category attached, or 81.1%. Encore Medical, LP accounts for 79.2% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $92,708 and has fallen 88.7% since, to $10,437 in 2025. Among adult reconstructive orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$227,265in general payments, 2019–2025

Across 105 payments — averaging $2164.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Encore Medical, LP$180K
  • Shalby Advanced Technologies, Inc.$33K
  • Kyocera Medical Technologies, Inc.$10K
  • Omnilife Science, Inc$2K
  • Corin USA$500
  • Stryker$360
  • plus $1K from 13 others
$72,854in research payments, 2019–2025

Across 24 payments — averaging $3035.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kyocera Medical Technologies, Inc.$50K
  • Zimmer Biomet$12K
  • Encore Medical, LP$11K

What the payments were for

  • Royalty or licence$184,35281%
  • Consulting fees$37,35016%
  • Food & beverage$5,5632%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$227,265 in reported general payments places this provider in the 90th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$336,120
Medicare patients
413
Services billed
1,493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen174$2,144
Oxycodone Hcl269$1,415
Meloxicam202$521
Tramadol Hcl56$186
Gabapentin24$183
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$167
Amoxicillin104$145
Diclofenac Sodium16$132
Hydromorphone Hcl15$89
Methocarbamol18$85
Cephalexin16$61

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Plano

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →